NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 319 filers reported holding NOVOCURE LTD in Q3 2021. The put-call ratio across all filers is 1.48 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $5,768,142 | +1007.1% | 78,639 | +1046.8% | 0.01% | +600.0% |
Q3 2022 | $521,000 | -74.7% | 6,857 | -75.0% | 0.00% | -50.0% |
Q4 2021 | $2,061,000 | -92.6% | 27,455 | -88.5% | 0.00% | -93.3% |
Q3 2021 | $27,811,000 | +51.3% | 239,403 | +188.9% | 0.03% | +50.0% |
Q2 2021 | $18,380,000 | -28.6% | 82,862 | -57.5% | 0.02% | -35.5% |
Q1 2021 | $25,745,000 | -44.6% | 194,776 | -27.5% | 0.03% | -50.0% |
Q4 2020 | $46,463,000 | +1691.2% | 268,508 | +513.8% | 0.06% | +1450.0% |
Q2 2020 | $2,594,000 | -41.6% | 43,744 | -33.7% | 0.00% | -60.0% |
Q1 2020 | $4,444,000 | -31.0% | 65,992 | -13.7% | 0.01% | -9.1% |
Q4 2019 | $6,444,000 | -6.3% | 76,464 | -16.9% | 0.01% | -15.4% |
Q3 2019 | $6,879,000 | +12.2% | 91,984 | -5.1% | 0.01% | +8.3% |
Q2 2019 | $6,130,000 | +28.5% | 96,943 | -2.1% | 0.01% | +33.3% |
Q1 2019 | $4,769,000 | +32.4% | 99,013 | -7.9% | 0.01% | 0.0% |
Q4 2018 | $3,601,000 | -60.8% | 107,546 | -38.6% | 0.01% | -47.1% |
Q3 2018 | $9,181,000 | +105.6% | 175,208 | +22.8% | 0.02% | +88.9% |
Q2 2018 | $4,465,000 | +79.2% | 142,665 | +24.8% | 0.01% | +50.0% |
Q1 2018 | $2,492,000 | -14.4% | 114,324 | -20.7% | 0.01% | -14.3% |
Q4 2017 | $2,912,000 | – | 144,155 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nordwand Advisors, LLC | 1,515,000 | $111,125,249 | 13.86% |
Invus Financial Advisors, LLC | 350,884 | $25,737,341 | 13.70% |
HARTLINE INVESTMENT CORP/ | 304,482 | $22,333,755 | 5.08% |
GREAT POINT PARTNERS LLC | 241,000 | $17,677,350 | 3.46% |
Tri Locum Partners LP | 72,400 | $5,311,000 | 2.15% |
Taylor Frigon Capital Management LLC | 42,061 | $3,085,174 | 1.75% |
HighVista Strategies LLC | 28,007 | $2,054,313 | 1.22% |
HAP Trading, LLC | 124,500 | $10,294 | 1.05% |
Private Harbour Investment Management & Counsel, LLC | 12,285 | $901,105 | 0.99% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 32,000 | $2,344,000 | 0.72% |